Role of CD200/CD200R Signaling Pathway in Regulation of CD4+T Cell Subsets During Thermal Ablation of Hepatocellular Carcinoma

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2019 Mar 7

PMID 30838977

Citations 4

Authors

Shengchuan Huang

Yan Pan

Qingdong Zhang

Weiping Sun

Affiliations

Soon will be listed here.

Abstract

BACKGROUND In this study, we assessed the role of CD200 and CD200 receptor (CD200R) in regulating CD4+T cell subsets and assessed the therapeutic efficacy of thermal ablation for liver hepatocellular carcinoma (HCC) in rats. MATERIAL AND METHODS Seventy-eight male C57BL/6 rats were randomly divided into 7 groups: a control group, a model group, a CD200FC group, an anti-CD200R1 mAb group, a thermal ablation group, a thermal ablation+CD200 FC group, and a thermal ablation+anti-CD200R1 mAb group. The levels of CD200, CD200R1, Th1, Th17, and Treg in peripheral blood were detected by flow cytometry. Immunohistochemistry was used to detect CD200, CD200R1, IFN-γ, IL-17, Foxp3 protein expression in tumor tissues. RESULTS The levels of CD200, CD200R1, Th17, and Treg were significantly increased after CD200FC treatment (p<0.05). After treatment with anti-CD200R1 mAb, the levels of CD200, CD200R1, Th17, and Treg decreased and Th1 increased. Compared with the control group, the expression of CD200, CD200R1, IL-17, and Foxp3 in the model group increased significantly, and the expression of IFN-γ decreased significantly (p<0.05). The expression of CD200, CD200R1, IL-17, and Foxp3 was significantly reduced by adding anti-CD200R1 mAb, and the expression of IFN-γ was increased (p<0.05). After the thermal ablation treatment, the proteins continued to decrease and the expression of IFN-γ continued to increase. CONCLUSIONS The CD200/CD200R pathway participates in HCC tumor growth and the expression of CD4+T cell subsets in cancer tissues. Furthermore, thermal ablation treatment inhibited cancer recurrence.

Citing Articles

Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.

Moon S, Han M, Ryu G, Shin S, Lee J, Lee C Int J Mol Sci. 2023; 24(20).

PMID: 37894750 PMC: 10606340. DOI: 10.3390/ijms242015072.

T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis integrating single-cell RNA-seq and bulk RNA-sequencing.

Chi H, Zhao S, Yang J, Gao X, Peng G, Zhang J Front Immunol. 2023; 14:1137025.

PMID: 37006257 PMC: 10050519. DOI: 10.3389/fimmu.2023.1137025.

EMT Factors and Metabolic Pathways in Cancer.

Georgakopoulos-Soares I, Chartoumpekis D, Kyriazopoulou V, Zaravinos A Front Oncol. 2020; 10:499.

PMID: 32318352 PMC: 7154126. DOI: 10.3389/fonc.2020.00499.

Current Perspectives in Cancer Immunotherapy.

Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A Cancers (Basel). 2019; 11(10).

PMID: 31575023 PMC: 6826426. DOI: 10.3390/cancers11101472.

References

Hoek R, Ruuls S, Murphy C, Wright G, Goddard R, Zurawski S . Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science. 2000; 290(5497):1768-71. DOI: 10.1126/science.290.5497.1768. View

Nathan C, Muller W . Putting the brakes on innate immunity: a regulatory role for CD200?. Nat Immunol. 2001; 2(1):17-9. DOI: 10.1038/83124. View

Clark D, Ding J, Yu G, Levy G, Gorczynski R . Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod. 2001; 7(2):185-94. DOI: 10.1093/molehr/7.2.185. View

Overgaard J . Influence of extracellular pH on the viability and morphology of tumor cells exposed to hyperthermia. J Natl Cancer Inst. 1976; 56(6):1243-50. DOI: 10.1093/jnci/56.6.1243. View

Toda Y, Tsukada J, Misago M, Kominato Y, Auron P, Tanaka Y . Autocrine induction of the human pro-IL-1beta gene promoter by IL-1beta in monocytes. J Immunol. 2002; 168(4):1984-91. DOI: 10.4049/jimmunol.168.4.1984. View

Hatherley D, Barclay A . The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur J Immunol. 2004; 34(6):1688-94. DOI: 10.1002/eji.200425080. View

Ali M, Grimm C, Ritter M, Mohr L, Allgaier H, Weth R . Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol. 2005; 43(5):817-22. DOI: 10.1016/j.jhep.2005.04.016. View

Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M . Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. Am J Pathol. 2007; 170(5):1695-712. PMC: 1854964. DOI: 10.2353/ajpath.2007.060677. View

Yu G, Sun Y, Foerster K, Manuel J, Molina H, Levy G . LPS-induced murine abortions require C5 but not C3, and are prevented by upregulating expression of the CD200 tolerance signaling molecule. Am J Reprod Immunol. 2008; 60(2):135-40. DOI: 10.1111/j.1600-0897.2008.00605.x. View

10.

Chen Z, Chen D, Kai Y, Khatri I, Lamptey B, Gorczynski R . Identification of an expressed truncated form of CD200, CD200tr, which is a physiologic antagonist of CD200-induced suppression. Transplantation. 2008; 86(8):1116-24. DOI: 10.1097/TP.0b013e318186fec2. View

11.

Koning N, Swaab D, Hoek R, Huitinga I . Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J Neuropathol Exp Neurol. 2009; 68(2):159-67. DOI: 10.1097/NEN.0b013e3181964113. View

12.

Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S . MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol. 2009; 10(12):1252-9. DOI: 10.1038/ni.1798. View

13.

Liu Y, Bando Y, Vargas-Lowy D, Elyaman W, Khoury S, Huang T . CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis. J Neurosci. 2010; 30(6):2025-38. PMC: 2837938. DOI: 10.1523/JNEUROSCI.4272-09.2010. View

14.

Chen Z, Ma X, Zhang J, Hu J, Gorczynski R . Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF. Nucleic Acids Res. 2010; 38(19):6684-96. PMC: 2965252. DOI: 10.1093/nar/gkq554. View

15.

Richter K, Haslbeck M, Buchner J . The heat shock response: life on the verge of death. Mol Cell. 2010; 40(2):253-66. DOI: 10.1016/j.molcel.2010.10.006. View

16.

Rygiel T, Karnam G, Goverse G, van der Marel A, Greuter M, van Schaarenburg R . CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor. Oncogene. 2011; 31(24):2979-88. DOI: 10.1038/onc.2011.477. View

17.

Hernangomez M, Mestre L, Correa F, Loria F, Mecha M, Inigo P . CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation. Glia. 2012; 60(9):1437-50. DOI: 10.1002/glia.22366. View

18.

Dentesano G, Straccia M, Ejarque-Ortiz A, Tusell J, Serratosa J, Saura J . Inhibition of CD200R1 expression by C/EBP β in reactive microglial cells. J Neuroinflammation. 2012; 9:165. PMC: 3414764. DOI: 10.1186/1742-2094-9-165. View

19.

Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L . MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol. 2013; 266(1-2):56-63. DOI: 10.1016/j.jneuroim.2013.09.019. View

20.

Xin L, Ertelt J, Rowe J, Jiang T, Kinder J, Chaturvedi V . Cutting edge: committed Th1 CD4+ T cell differentiation blocks pregnancy-induced Foxp3 expression with antigen-specific fetal loss. J Immunol. 2014; 192(7):2970-4. PMC: 3972488. DOI: 10.4049/jimmunol.1302678. View